Bioinformatic Analysis of GCN1 as a Novel Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma and Preliminary Exploration of Its Molecular Mechanisms
Table 1.
Baseline Characteristics
|
| Characteristics |
overall |
|
|
| Pathologic T stage, n (%) |
|
|
| T1 |
101 (61.6%) |
|
| T2&T3&T4 |
63 (38.4%) |
|
| Pathologic N stage, n (%) |
|
|
| N0 |
163 (99.4%) |
|
| N1 |
1 (0.6%) |
|
| Pathologic M stage, n (%) |
|
|
| M0 |
161 (98.2%) |
|
| M1 |
3 (1.8%) |
|
| Gender, n (%) |
|
|
| Male |
110 (67.1%) |
|
| Female |
54 (32.9%) |
|
| Age, n (%) |
|
|
| <= 60 |
91 (55.5%) |
|
| > 60 |
73 (44.5%) |
|
| BMI, n (%) |
|
|
| <= 25 |
95 (57.9%) |
|
| > 25 |
69 (42.1%) |
|
| AFP (ng/ml), n (%) |
|
|
| <= 400 |
123 (75%) |
|
| > 400 |
41 (25%) |
|
| Albumin(g/dl), n (%) |
|
|
| < 3.5 |
36 (22%) |
|
| >= 3.5 |
128 (78%) |
|
| Prothrombin time, n (%) |
|
|
| <= 4 |
130 (79.3%) |
|
| > 4 |
34 (20.7%) |
|
| Vascular invasion, n (%) |
|
|
| No |
111 (67.7%) |
|
| Yes |
53 (32.3%) |
|
|
|
|
